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Summary In anorexia nervosa (AN), hyperactivity is observed in about
80% of patients and has been associated with low leptin levels in the
acute stage of AN and in anorexia animal models. To further understand
the importance of this correlation in AN, we investigated the relationship
between hypoleptinaemia and hyperactivity in AN patients longitudinally
and assessed their predictive value for recovery.
Body weight, activity levels, and serum leptin levels were assessed
in adolescents and adult AN patient groups at the start and during
treatment, up to a year. In the adolescent group, initial leptin and ac-
tivity levels were correlated. This negative correlation changes over time
into a positive correlation with physiological recovery. Treatment out-
come in both groups could be predicted by initial BMI and leptin levels
but not by activity levels. No major relationship of activity with the
course of recovery was detected, suggesting that in contrast to the acute
stage of the disease, leptin and activity levels during the recovery pro-
cess are dissociated.
Keywords: Anorexia nervosa; hyperactivity; leptin; recovery; eating dis-
orders; physical activity
Introduction
Anorexia nervosa (AN) is a complex eating disorder of un-
known etiology, which primarily affects adolescent girls
and young women (Lucas et al., 1991, 1999; Hoek and
Hoeken, 2003). It is characterized by aberrant patterns of
eating behavior and weight regulation which result in weight
loss and endocrine abnormalities such as amenorrhea, dis-
turbances in attitude and perception about weight and shape,
and an intense fear of gaining weight (American Psychiatric
Association, 1994).
Other symptoms, such as perfectionism, obsessive-
compulsive behavior, and social anxiety are observed in
many but not all patients (Piran et al., 1985; Casper and
Jabine, 1996). In addition, a proportion of AN patients
(31–80%, Hebebrand et al., 2003) displays abnormally high
physical activity levels and overexercises. Almost all pa-
tients show a constant, agitated restlessness when they are
emaciated but before they become lethargic in the ﬁnal
stages of starvation. The exact nature of hyperactivity in
anorexia nervosa remains to be clariﬁed. It appears that
neurobiological factors and conscious attempts to burn
calories in order to loose more weight coexist (Casper,
1998, 2006).
Animal models mimicking AN weight loss and hyper-
activity, such as the activity based anorexia (ABA) model
(Routtenberg and Kuznesof, 1967; Kas et al., 2003) or the
semistarvation induced hyperactivity (SIH) model (Pirke,
1993; Exner et al., 2000) have been helpful in the search
for a possible biological drive or changes in physiological
parameters that trigger food restriction and hyperactivity.
Studies using these preclinical models showed that anorec-
tic rats (Kas et al., 2003) and mice (Gelegen et al., 2007)
have reduced plasma leptin levels and that treating food
restricted rats with leptin suppresses the development of
hyperactivity (Exner et al., 2000; Hillebrand et al., 2005a).
Leptin is an adipocyte secreted hormone, product of the
ob gene (Zhang et al., 1994), which plays a pivotal role in
starvation situations with regard to energy homeostasis as
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Plasma leptin levels rapidly decrease during weight loss
(Ahima et al., 1996) and are extremely low in AN patients
(Calandra et al., 2003). However, leptin levels in recently
weight recovered patients have been found to be higher
than in BMI-matched controls, and are thought to con-
tribute to difﬁculties with further weight restoration and
maintenance (Eckert et al., 1998; Holtkamp et al., 2004;
Mantzoros et al., 2006). Holtkamp et al. have shown that
patients leptin levels are negatively correlated with motor
restlessness scores (2003) and with physical activity in
acutely ill AN patients (2006). Thus, pre-clinical and clin-
ical observations suggest that hypoleptinemia is an impor-
tant factor underlying excessive physical activity in AN.
The meaning of these ﬁndings for recovery have however
not been studied in detail to date.
The objective of this study was to investigate the re-
lationship between hyperactivity, serum leptin levels, and
recovery in AN patients.
Materials and methods
Subjects
Patients were included in the study after they and=or their parents gave in-
formed consent. The samplewas recruited in two specialized eating disorder
treatment centers (clinics), one for adolescents 12–17 years (the University
Medical Center Utrecht [UMCU], 31 subjects) and one for adults older than
17 years (Rintveld, 30 subjects). The clinical research protocol for this
prospectively designed, cohort follow-up study was approved by the UMCU
Ethics Review Committee.
Inclusion criteria were: (1) AN diagnosed according to the DSM-IV
(American Psychiatric Association, 1994) on the basis of a structured in-
terview using the Eating Disorders Examination (Cooper et al., 1989);
(2) comorbidity restricted to depression or anxiety disorders; (3) secondary
amenorrhea; (4) no use of steroid contraceptives; (5) no clinical history of
concurrent illnesses. Sixty-one female patients were included, 24 of the AN
purging type, 37 of the AN restricting type.
Study design
After initial psychiatric assessment, patients entered a structured treatment
program aimed at restoration of the patient’s weight, normalization of eating
patterns, body image, anorectic cognitions and family and social function-
ing. Weight gain was targeted at 0.5–1.0kg=week in accordance with
clinical guidelines. Weight recovery was deﬁned as a weight within the
normal range for age (>SD  1.5 corresponding with a body mass index
[BMI] of approximately 19kg=m
2 for adults) and target weight as the
weight at which patients resumed a regular menstrual cycle, deﬁned as
three menstrual periods at three to ﬁve week intervals. Individual, group
and family therapy techniques were used to change the patients’ aberrant
body perception and cognition.
Data was collected from patient acceptance into the treatment program, in
the acute stage of the illness, until the end point, deﬁned as recovery (return
of regular menses), or up to one year after begin of treatment.
Body weight was measured once a week. The degree of underweight
was calculated using BMI (kg=m
2) and BMI computed into z scores which
describe the distance in SD from the mean BMI for that age (using a
software program provided by the Netherlands Organization for Applied
Scientiﬁc Research to account for differences in age) and to relate the data
to Dutch population references (Van Buuren and Fredriks, 2001).
Blood samples for hormonal analysis were obtained by venepuncture at
admission and every two weeks thereafter at 4pm, up to the maximum study
period of one year.
Activity measures
Physical activity levels were measured by trained nurses once a week. In
an earlier study using actometer measurement as gold standard we estab-
lished the reliability and validity of nurse observations of patient activity
(Van Elburg et al., 2007). Nurses were instructed to observe activity, deﬁned
as the amount of motor restlessness (inability to sit still or moving arms or
legs while seated, walking through the ward without reason), abnormal
motor activity, and excessive exercise, and to score their observations on
a visual analogue scale (0–10).
Leptin assay
Plasma samples were stored at  80 C prior to determination. Leptin was
measured using a sensitive RIA (Human-Leptin-RIA sensitive, Mediagnost,
Tubingen, Germany), intra-assay CVof 5%, inter-assay CVof 7.6%.
Statistics
At the study endpoint, follow-up data was collected on the basis of which,
patients were divided into three groups according to their recovery stage: no
weight recovery (NWR), weight recovery without resumption of menses
(WR) and weight and cycle recovery (WCR). Data are presented as the
mean   SD if distributed normally, otherwise as the median and range.
Kruskal–Wallis tests were used if data were not normally distributed.
In case data were normally distributed ANOVA was used. Linear multi-
ple regression analysis (backward elimination) was also carried out to
predict physical activity using BMI z scores and log10 leptin levels as
predictor variables. A p-value of<0.05 was considered to be statistically
signiﬁcant.
To determine the associations of weight, leptin and physical activity
levels with the rate of recovery as deﬁned by the menstrual cycle at end
point, univariate and multivariate Cox proportional hazards analyses were
performed. This method of analysis estimates a linear regression model of
parameters against the logarithm of the hazard (or instantaneous risk) of the
menstrual cycle recovery during follow-up. Initial values of parameters were
used as potential predictors. Parameters with univariate p<0.30 were can-
didate predictors for the multivariate model; backward elimination of pa-
rameters (with p<0.05 for inclusion) was used to determine the set of
most predictive parameters. Because of potential differences in prognosis
averages between the two treatment centers, the analysis was stratiﬁed by
clinic. The analysis was ﬁrst performed with initial values of weight, leptin
and physical activity levels as predictors and subsequently with longitudinal
values, using Cox regression with time-dependent covariates. A further
analysis of longitudinal data focused on the evolvement of the association
between leptin levels and activity levels during the course of treatment. A
linear mixed model was used, predicting physical activity from log10 leptin
levels, follow-up time measured in weeks and ﬁnal recovery status as
predictor variables. A potential difference between the recovered and non-
recovered group in the evolvement of the association between leptin levels
and activity levels over time was tested by an interaction of (log10 leptin)
 week  group.
Statistical analysis was performed using SPSS for Windows (release 11.5,
SPSS Inc., Chicago, IL) and S-plus software (MathSoft Inc., Seattle, WA,
version 2000).
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The mean age of the whole patient group was 18.2   3.1
(SD) years, 15.9   1.2 years for the adolescent group and
20.6   2.9 years for the adult group. Average BMI at ad-
mission was 15.4   1.3kg=m
2, which corresponds to a BMI
z score of  3.8   1.6 (Table 1). Within the one year time
frame of the study, 42 (69%) patients met the weight re-
covery objectives. Of them 24 (39% of the total, 57% of
the weight recovered group) also recovered their menstrual
cycles; 18 patients recovered in weight without the resump-
tion of a menstrual cycle. Nineteen patients (31%) remain-
ed at a low weight throughout the year.
There were no signiﬁcant differences among the three
outcome groups in initial body weight, duration of illness
(deﬁned by duration of amenorrhea), duration of study par-
ticipation, type of AN (restrictive or purging type), plasma
leptinlevels,nurseratingsofphysicalactivitylevels,amount
of prescribed neuroleptics, or SSRIs (Table 1). Fourteen
patients used olanzapine, 7 in each group (clinic) with
dosages ranging from 5 to 15mg=day, average dose 7.5mg
in both clinics. A difference in age was observed. The group
that recovered in weight and resumed a menstrual cycle was
signiﬁcantly older than the non-recovered group, which re-
sult also corresponds with the clinic where they were treated.
Rates of recovering weight and menstrual cycle differed in
the two clinics: 16% of the patients in the adolescent group
recovered versus 63% of the patients in the adult group.
For the group as a whole, initial leptin levels did not cor-
relate with nurse ratings of activity, the scatter plot showing
a U-shape (p¼0.082). After stratiﬁcation by clinic and ad-
justed for BMI z sore, the adolescent patient group showed
a linear association between activity levels and log10
serum leptin levels (partial correlation:  0.40, p¼0.027),
whereas the adult group shows the U-shaped scatter plot,
p¼0.12 (Fig. 1).
Next, we analyzed the predictive value of initial BMI
z score, activity and plasma leptin levels on complete
(weight and cycle) recovery. In a univariate analysis, initial
leptin levels and initial BMI z scores predicted a favourable
outcome, whereas initial activity levels showed no correla-
tion. Multivariate analysis showed that leptin was the sole
signiﬁcant variable (Table 2).
Analysis of the longitudinal data using a Cox model with
time-dependent covariates showed leptin and BMI z score
as main inﬂuences on recovery of menstrual cycle. Adding
Table 1. Demographics (mean   SD) of 61 young women diagnosed with anorexia nervosa. Data are presented for the entire group, and separately for
women presenting with no weight recovery (NWR), with weight recovery (WR) only and with weight   cycle recovery (WCR) during the study period of
maximum 12 months
Variables Total group (n¼61) NWR (n¼19) WR (n¼18) WCR (n¼24)
Age (years) 18.2   3.1 17.3   2.2 16.9   3.2 19.8   3.0  vs: NWR þ WR
Weeks in study 33.5   11.4 32.8   11.6 36.9   14.0 31.6   8.8
Bodyweight, initial z scores  3.8   1.6  4.2   1.9  3.2   1.5  3.8   1.2
Bodyweight end of study  1.3   1.1  2.1   0.8  vs: WCR þ WR  0.9   0.5  0.9   0.6
Amenorrhea (months) 24.4   22.8 20.5   13.5 30.0   30.5 23.9   23.6
Initial leptin (mg=l) 2.1 (0.5–13.3) 2.9 (0.7–8.6) 1.5 (0.5–4.6) 2.4 (0.7–13.3)
AN restrictive type (%) 69 79 72 58
Neuroleptics (%) 57 47 55 58
SSRIs (%) 33 26 22 50
Initial activity score 52.5   26.9 49.1   27.9 56.2   24.9 52.4   28.8
  p<0.01
Fig. 1. Scatter plot of initial log10 serum leptin levels versus observed
levels of levels of activity in two groups of patients with AN. Activity is
deﬁned as the amount of motor restlessness, abnormal motor activity and
excessive exercise, as observed by nurses. p¼0.027 for the adolescent
group (N¼31), p¼0.12 for the adult group (N¼30)
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The linear mixed model analysis showed that the recovered
(WCR) and non-recovered patients (WR and NWR) differ-
ed signiﬁcantly in the way the relationship between leptin
and physical activity changed during the treatment period
(P¼0.016, test for interaction): the correlation between
leptin and physical activity remained the same during treat-
ment (r¼ 0.28) in the NWR and WR groups, whereas
in the WCR group it changed from an initial value of
r¼ 0.22 at 16 weeks to r¼þ0.58 at 52 weeks.
Discussion
In this longitudinal study we measured body weight, plasma
leptin levels, and activity levels in a clinical sample of AN
patients during recovery.
We replicated the ﬁnding from animal and human studies
(Kas et al., 2003; Holtkamp et al., 2003, 2006) that initial
log10 leptin levels and activity levels in the acute stage of
the illness in a young patient population are correlated, and
found a linear correlation in our adolescent age group. In
our adult group we found a U shaped correlation between
activity and plasma leptin levels, which suggests that hy-
peractivity is age-related. Over time however, physical
activity did not predict outcome and no major relation-
ship between physical activity levels and the course of
recovery could be detected for neither the adolescent nor
the adult group.
Contrary to Holtkamp (2003) we rated activity during
treatment and observed by nurses instead of relying on an-
amnestic reports of physical activity in the months before
admission or during the acute stage of the illness. In an
earlier study (Van Elburg et al., 2007) we showed that
nurses can reliably rate physical activity levels of anorexia
nervosa patients. Measurements of a patient’s physical
activity levels by nurses correlate with activity scores from
actometers, the gold standard reference. Patient self-reports
did not correlate with the actometer scores. In clinical
practice a variety of methods has been used to evaluate hy-
peractivity, but based on our previous ﬁndings conclusions
drawn from studies using self-report or expert report not
basedonobservation shouldbeconsideredonlywithcaution.
Once patients were divided into different outcome groups
at the end of the study period differences in levels of phy-
sical activity and leptin were found, even though initial
levels were not signiﬁcantly different. Initial plasma leptin
levels for all groups were clearly below normal values.
Only the WCR-group reached average levels in the normal
range at the end of the study period. WR patients clearly
responded to treatment and recovered in weight, however,
their subnormal leptin levels most probably did not permit
them to recover at the level of the gonadal axis.
Several studies (Haupt et al., 2005; Wang et al., 2006)
have discussed the relationship between leptin and the use
of atypical antipsychotics such as olanzapine, so far only
in normal weight schizophrenic or psychotic patients. The
results show that olanzapine in the ﬁrst weeks of treatment
may cause a surge in circulating leptin (Wang et al., 2006)
but that elevated plasma leptin levels in chronically treated
patients with schizophrenia are strongly predicted by
adiposity, similar to untreated healthy individuals (Haupt
et al., 2005).
In a previous study (Hillebrand, 2005b), we demonstrat-
ed that olanzapine reduces activity levels in AN patients
without affecting body weight and plasma leptin levels. In
our current study, 57% of patients used antipsychotics
(neuroleptics), which might have inﬂuenced the relation-
ship between leptin and activity scores. However, Cox
regression analysis with medication as predictor showed
no correlation (univariate: neuroleptics: p¼0.6, SSRIs:
p¼0.3). Holtkamp et al. (2003, 2006) unfortunately do
not report use of neuroleptics in their study populations.
In summary, our study replicates earlier ﬁndings in both
rodents and humans that hypoleptinaemia and high physi-
cal activity levels are related in acutely ill AN patients of a
young age, but we did not ﬁnd the same relationship in an
older patient group. The negative correlation between lep-
tin and activity that exists in the acute phase of the illness
Table 3. Time-dependent analysis of the association of BMI z scores, leptin







BMI z score <0.001 0.003 2.1 (1.3–3.3)
Leptin <0.001 0.022 1.12 (1.02–1.24)
Activity 0.9
  Hazard ratio for standardised parameters, with 95% conﬁdence interval.
The hazard ratio represents the change in hazard when the parameter is
increased by one standard deviation
Cox regression stratiﬁed by clinic
Table 2. Association of initial BMI z scores, leptin, and activity levels with







BMI z score 0.0014 0.15
Leptin level <0.001 <0.001 1.97 (1.31–2.97)
Activity level 0.84 0.96
  The change in hazard when the parameter is increased by one standard
deviation
Cox regression stratiﬁed by treatment center
1236 A. A. van Elburg et al.changes over the course of 16 weeks to become a positive
correlation in the second half of the treatment period, as a
result of recovery. In the non recovered patients the nega-
tive correlation continues. Furthermore, our data indicate
that plasma leptin level is a good predictor of recovery in
AN, however, we could not detect any major relationship
between physical activity levels and the course of recovery.
The latter indicates that leptin and physical activity levels
during the recovery process are, in contrast to the acute
stage of the disease, dissociated. Further detailed assess-
ment of this relationship is required to elaborate on these
ﬁndings and their implications for clinical practice.
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